[Incidence and predictors of 90-day poor clinical outcome after successful endovascular treatment for acute basilar artery occlusion]
- PMID: 37544759
- DOI: 10.3760/cma.j.cn112137-20230103-00008
[Incidence and predictors of 90-day poor clinical outcome after successful endovascular treatment for acute basilar artery occlusion]
Abstract
Objective: To investigate the incidence and predictors of 90-day poor clinical outcome after successful endovascular treatment for acute basilar artery occlusion. Methods: Patients were selected from the Acute Ischemic Stroke Cooperation Group of Endovascular Treatment (ANGEL) registry, which was a prospective, multicenter registry study between June 2015 and December 2017. The demographic characteristics, past history, personal history, vital signs, National Institutes of Health Stroke Scale (NIHSS) score, imaging examination, onset/admission/puncture/end of operation, operation-related variables, medication during operation, patency of occluded blood vessels after operation, etiology classification, and 90-day modified Rankin scale (mRS) score were collected. Successful endovascular treatment was defined as modified thrombolysis in cerebral infarction (mTICI) 2b-3. Poor outcome was defined as 90-day mRS 4-6. Multivariate logistic regression analysis was performed to analyze the predictors of poor clinical outcome after successful endovascular treatment. Results: A total of 170 (128 males and 42 females) acute basilar artery occlusion patients undergoing successful endovascular treatment were included in the analysis, with the median age of [M (Q1, Q3)] of 64 (55, 70) years. Poor clinical outcome occurred in 72 patients (42.4%). Multivariate logistic regression analysis revealed that high baseline NIHSS score (OR=1.166, 95%CI: 1.109-1.225, P<0.001) and high baseline systolic blood pressure (OR=1.032, 95%CI: 1.010-1.053, P=0.003) were the independent predictors of poor clinical outcome. Conclusions: The incidence of 90-day poor clinical outcome after successful endovascular treatment for acute basilar artery occlusion is 42.4%. High baseline NIHSS score and systolic blood pressure are associated with the poor clinical outcome.
目的: 探索急性基底动脉闭塞血管内治疗成功再通后90 d的不良临床结局的发生率和相关因素。 方法: 本研究的研究人群来自一项于2015年6月至2017年12月的多中心、前瞻性、登记研究:血管内治疗急性缺血性脑卒中协作组(ANGEL)登记研究。收集患者的人口统计学特征,既往史,个人史,生命体征,美国国立卫生研究院卒中量表(NIHSS)评分,影像学检查,发病/入院/穿刺/手术结束时间点,手术相关变量,术中用药情况,术毕闭塞血管开通情况,病因分型,90 d改良Rankin量表(mRS)评分。血管内治疗术毕成功再通的定义为改良脑梗死溶栓(mTICI)分级2b~3级,不良临床结局定义为患者90 d mRS评分4~6分。多因素logistic回归模型分析来确定不良临床结局的相关因素。 结果: 170例接受血管内治疗且成功再通的急性基底动脉闭塞患者纳入本研究,男性128例,女性42例,年龄[M(Q1,Q3)]64(55,70)岁。其中72例患者(42.4%)发生了不良临床结局,98例患者(57.6%)发生了良好临床结局。多因素logistic回归模型分析结果显示,高基线NIHSS评分(OR=1.166,95%CI:1.109~1.225,P<0.001)和高术前收缩压(OR=1.032,95%CI:1.010~1.053,P=0.003)是不良临床结局的相关影响因素。 结论: 急性基底动脉血管内治疗成功再通后90 d不良临床结局的发生率为42.4%,高基线NIHSS评分和高术前收缩压与不良临床结局相关。.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous